We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases
Vandria SA is a dynamic biopharmaceutical company focused on developing innovative solutions for age-related and chronic diseases. Vandria SA is dedicated to creating best-in-class small molecule mitophagy inducers that rejuvenate cells, addressing significant unmet medical needs in muscle and CNS disorders.
Located in EPFL Innovation Park, Building E, Lausanne, 1015, CH, Vandria SA operates at the forefront of pharmaceutical manufacturing. The company's commitment to cutting-edge research and development positions Vandria SA as a key player in the future of biopharmaceuticals, aiming to improve patient outcomes through groundbreaking therapies.
Vandria SA is poised for substantial growth and commercial development in the biopharmaceutical sector. We invite Vandria SA's management to create a customized and exclusive company showcase and product listing on our platform, further enhancing their market presence and reach.
Other organizations in the same industry
This company is also known as